Search

2025 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing [...]

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full Marketing Authorization (MA) by the European Commission in the European Union (EU) for [...]

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, announced that Nuvaxovid (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary [...]

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Medicines Agency (EMA) has accepted a variation for the evaluation of a 50 ôg [...]

Pfizer Inc. and BioNTech SE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended converting the conditional Marketing Authorization (cMA) [...]

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid (NVX-CoV2373) Covid-19 vaccine has been recommended for expanded conditional marketing authorization [...]

Pfizer Inc. and BioNTech SE announced a 30-ôg booster dose of their Omicron BA.1 Bivalent Covid-19 vaccine (Comirnaty Original/Omicron BA.1 15/15 ôg) has been recommended for conditional marketing authorization (cMA) [...]

Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a [...]

This year's MM+M Awards will be a hybrid event taking place on October 7. The in-person element will return to Cipriani Wall Street. For tickets and more information, visit www.mmm-awards.com/ [...]

StellaLife markets a set of products that it says relieves pain and swelling after gum and dental surgery. At its website, StellaLife offers gushing testimonials and fawning videos of dentists [...]

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for [...]

Atlas Biotechnologies announced the launch of Atlas Thrive - Powered by MUV branded products in collaboration with multi-state American partner Verano Holdings. Powered by MUV patches, gels and tinctures will [...]

Bluebird Bio, announced that the European Medicines Agency's, or EMA, Pharmacovigilance Risk Assessment Committee, or PRAC, has concluded based on the review of all available data that the benefit-risk balance [...]

A new resource for biotech and digital health companies has launched in Glendale. A lab digitization service known as eLabNext opened an office this month at Hero House, a tech [...]

As biotechs grow in market prominence, the reality is dawg that their pharmacovigilance (PV) obligations are equivalent to those of pharma companies several ties their size. For young, ambitious, product-oriented [...]

James Chase (MM&M): What does patient-centricity mean to each of you? Fatima Scipione (Millennium Pharmaceuticals): When I took this position, it was the first time that our organization had someone [...]

A study was conducted to show that the requirement for industry-specific knowledge development applies to the life science industry. Marketers within the industry face challenges along decision areas in therapy creation, therapy launch, and therapy promotion. It is concluded that marketing of the life sciences offers a fertile area for further research.

Abe Ceesay Product manager, Synvisc, Genzyme Age: 28 Years in the industry: 4 Abe Ceesay believes that the opportunity to work for an organization that always does what is right [...]

The commercialization activities of biotechnology-based companies in a European context are addressed and whether these companies are able to gain adequate market perceptions are discussed. Adequate marketing process is set taking into account three analytical steps, strategic marketing definition, marketing implementation, and evolution of strategy and implementation.

The identification of important non-financial performance indicators is essential when assessing value creation in emerging industries. Identification of such performance indicators helps managers within these industries determine what should be [...]

This article begins with a preface to what genetic testing is, and then describes the costs, advantages, and disadvantages of such testing, including privacy issues that have yet to be resolved. Myriad Genetics is one company that offers such tests, and its marketing information has been described as misleading.

Management is the need of the hour for small biotech companies in Australia. Success in the area of biotechnological company depends on smart science and astute management and marketing.

Chief executive officers of biotechnology companies are rightfully focused on keeping equity financing flowing, R&D on track, corporate dealmakers interested, and burn rate in check. Clearly, these are the initial [...]